VC
ABBV icon

Veracity Capital’s AbbVie ABBV Stock Holding History

Veracity Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
4,514
-60
-1% -$12.9K 0.31% 62
2026
Q1 		$995K Sell
4,574
-296
-6% -$65.7K 0.36% 52
2025
Q4 		$1.11M Sell
4,870
-4
-0.1% -$911 0.33% 53
2025
Q3 		$1.13M Buy
4,874
+1,408
+41% +$287K 0.36% 53
2025
Q2 		$643K Sell
3,466
-666
-16% -$124K 0.22% 103
2025
Q1 		$866K Sell
4,132
-550
-12% -$107K 0.34% 65
2024
Q4 		$832K Buy
4,682
+338
+8% +$62.1K 0.3% 71
2024
Q3 		$858K Sell
4,344
-22
-0.5% -$4.11K 0.33% 61
2024
Q2 		$749K Sell
4,366
-939
-18% -$156K 0.31% 64
2024
Q1 		$966K Sell
5,305
-335
-6% -$57.7K 0.38% 57
2023
Q4 		$874K Buy
5,640
+170
+3% +$24.8K 0.35% 58
2023
Q3 		$815K Buy
5,470
+233
+4% +$34.2K 0.38% 55
2023
Q2 		$706K Sell
5,237
-78
-1% -$11.4K 0.3% 78
2023
Q1 		$847K Sell
5,315
-70
-1% -$10.7K 0.39% 53
2022
Q4 		$870K Buy
5,385
+52
+1% +$7.97K 0.42% 53
2022
Q3 		$716K Buy
5,333
+189
+4% +$27.1K 0.39% 56
2022
Q2 		$788K Sell
5,144
-2
-0% -$306 0.42% 54
2022
Q1 		$834K Buy
5,146
+1,536
+43% +$223K 0.35% 65
2021
Q4 		$489K Buy
3,610
+196
+6% +$23.2K 0.2% 128
2021
Q3 		$368K Sell
3,414
-43,371
-93% -$4.96M 0.16% 147
2021
Q2 		$5.21M Buy
46,785
+43,467
+1,310% +$4.9M 1.21% 16
2021
Q1 		$359K Buy
3,318
+366
+12% +$39.1K 0.16% 152
2020
Q4 		$316K Sell
2,952
-1,103
-27% -$106K 0.16% 154
2020
Q3 		$355K Sell
4,055
-9,663
-70% -$910K 0.2% 123
2020
Q2 		$1.35M Sell
13,718
-12,209
-47% -$1.07M 0.78% 25
2020
Q1 		$1.98M Buy
25,927
+21,751
+521% +$1.85M 0.57% 41
2019
Q4 		$370K Buy
+4,176
New +$347K 0.1% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Veracity Capital's ABBV Position: Q2 2026 in Review

Veracity Capital reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $12.9K and leaving 4,514 shares worth $1.14M. The position accounts for 0.31% of the portfolio, ranked #62.

Veracity Capital first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.21M in Q2 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Veracity Capital held 4,514 shares of AbbVie worth $1.14M as of Q2 2026.
  • Veracity Capital sold 60 AbbVie shares in Q2 2026, an estimated $12.9K.
  • AbbVie made up 0.31% of Veracity Capital's portfolio in Q2 2026, its #62 holding.
  • Veracity Capital first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Veracity Capital's AbbVie position peaked at $5.21M in Q2 2021.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.